Followers | 1 |
Posts | 70 |
Boards Moderated | 0 |
Alias Born | 02/27/2019 |
Wednesday, April 22, 2020 11:09:44 AM
https://ir.exactusinc.com/presentations
Unfortunately, the actual presentation does not contain any new information, in fact some of it is old and incorrect.
For example, it still lists Steven A. Schwartz as Director of Exactus, even though he resigned, and was indicted for wire fraud in connection with the 1 Capital scam.
https://www.justice.gov/usao-sdfl/pr/former-consultantchief-operating-officer-1-global-capital-llc-pleads-guilty-role-wire
(Just one of Exactus' multiple associations with questionable individuals)
It looks like Exactus is headed towards bankruptcy. I am curious, why they would put a recent date on this old powerpoint, and also who buys shares nowadays. Everyday a few thousand dollars worth of shares are being bought. It is really doubtful that common shareholders will recover anything in bankruptcy, given the pending debts, claims, and accounts payables that the company has disclosed.
Recent PLSH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM